| Literature DB >> 25075174 |
Yayoi Otsu1, Masato Matsuoka1, Kayako Matsuyama1, Tetsuya Nishimura1.
Abstract
BACKGROUND: The purpose of this study was to determine the clinical features of patients with type 2 diabetes, and less ophthalmic examinations, referred by general physicians to ophthalmologists.Entities:
Keywords: albuminuria; diabetic retinopathy; general physician; ophthalmologists
Year: 2014 PMID: 25075174 PMCID: PMC4106958 DOI: 10.2147/OPTH.S65707
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Clinical characteristics
| Category | Total | Noncompliant | Never-examined | |
|---|---|---|---|---|
| Patients (n) | 327 | 124 | 203 | N/A |
| Age (years) | 60.0±14.0 | 63.0±14.0 | 58.1±13.8 | 0.001 |
| Sex (male/female) | 229/98 | 86/38 | 143/60 | N/A |
| BCVA (logMAR) | 0.037±0.36 | 0.15±0.53 | −0.03±0.18 | 0.004 |
Notes: Values are shown as the mean ± standard deviation.
P-value between noncompliant group and never-examined group (Mann–Whitney U-test).
Abbreviations: BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; N/A, not applicable.
Prevalence of diabetic retinopathy
| Category | Total (%) | Noncompliant (%) | Never-examined (%) | |
|---|---|---|---|---|
| Total (n) | 327 | 124 | 203 | N/A |
| DR (n) | 102 (31.2) | 59 (47.6) | 43 (21.2) | <0.001 (3.4) |
| M-NPDR | 81 (24.8) | 48 (38.7) | 33 (16.3) | <0.001 (3.3) |
| S-NPDR | 11 (3.4) | 2 (1.6) | 9 (4.4) | 0.29 (0.4) |
| PDR | 10 (3.1) | 9 (13.8) | 1 (0.6) | 0.002 (15.8) |
Note:
P-value from the comparison of prevalence of DR between never-examined group and noncompliant group.
Abbreviations: DR, diabetic retinopathy; M-NPDR, mild to moderate nonproliferative diabetic retinopathy; OR, odds ratio; S-NPDR, severe nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; N/A, not applicable.
Biochemistry results
| Category | Total | Noncompliant | Never-examined | |
|---|---|---|---|---|
| HbA1c (%) | 8.8±2.3 | 8.1±2.0 | 9.1±2.4 | <0.001 |
| sCre (mg/dL) | 0.9±1.1 | 1.0±0.8 | 0.9±1.2 | 0.020 |
| eGFR (mL/min) | 79.8±28.6 | 72.3±25.1 | 84.2±29.6 | 0.003 |
| uCre (mg/dL) | 106±78.5 | 99.8±71.2 | 110±82.3 | 0.428 |
| uAlb (mg/L) | 251±1,046 | 365±1,140 | 188±989 | 0.002 |
| uACR (mg/g·Cre) | 266±931 | 428±1,291 | 176±638 | 0.001 |
Notes: Mean ± standard deviation.
P-value between noncompliant group and never-examined group (Mann–Whitney U-test).
Abbreviations: HbA1c, glycosylated hemoglobin; sCre, serum creatinine; eGFR, estimated glomerular filtration rate; uCre, urinary creatinine; uAlb, urinary albumin; uACR, urine albumin/creatinine ratio.
Multiple regression analysis of severity of diabetic retinopathy
| Independent variable | β | |
|---|---|---|
| Group | −0.14 | 0.047 |
| Age | 0.03 | 0.683 |
| BCVA | 0.05 | 0.466 |
| HbA1c | 0.13 | 0.053 |
| eGFR | −0.01 | 0.954 |
| uACR | 0.25 | <0.001 |
Notes: Adjusted R2=0.11 for final BCVA in multiple regression (P<0.001);
standard partial regression coefficient;
noncompliant group or never-examined group.
Abbreviations: BCVA, best-corrected visual acuity; HbA1c, glycosylated hemoglobin; eGFR, estimated glomerular filtration rate; uACR, urine albumin/creatinine ratio.